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1. Introduction  
Electroretinography (ERG) is an important clinical tool that provides an objective 
quantitative measure of retinal function. Decreased a and b wave amplitudes and prolonged 
latencies correlate to reductions in retinal function that may be the result of toxicity, 
ischemic damage, or retinal dystrophy (Fishman et al. 2001, Ophthalmology monographs). 
Furthermore, since the different components of the ERG waveform correspond to the 
different layers of the retina, one is able to attribute changes in the ERG to damage to 
specific retinal layers. This data can be a useful surrogate for retinal health, for example 
establishing safety profiles for drugs under clinical development. 
Since 1989 the International Society for Clinical Electrophysiology of Vision (ISCEV) has 
provided standards for the recording of ERGs. These documents provide a framework for 
the clinical electrophyisologist to obtain “standard” ERG recordings (Marmor 1989). The 
variety of permissible ERG instruments and their individual calibration requirements 
contributes to significant inter-laboratory variability. This variability is recognized in the 
ISCEV standards and partly addressed by stating “it is incumbent on the manufactures and 
users to verify that full-field stimulation meets the requirements of this standard.” Placing  
the onus for compliance on the manufactures but leaving the clinical electrophyisologist to 
determine if the recording standards are indeed met.  
ERG standards have extended beyond the a- and b-wave of the full field flash ERG. The 
pattern ERG (PERG) is the electroretinal response to a pattern reversing stimulus such as bar 
gratings or checkerboard pattern. The PERG primarily reflects ganglion cell function and 
since it is viewed on display monitors it largely represents ganglion cell function within the 
macula. The peak and trough components of the PERG have been formally defined as the 
N35, P50 and N95 which represent the polarity (Negativity or Positivity) and the mean 
latency of occurrence. The ISCEV has produced standards for the recording and reporting of 
the PERG (Holder et al. 2007).  
While the PERG provides a single waveform which represents the electroretinal response of 
the entire macular region, the clinical multifocal electroretinogram (mERG) provides 
information of local retinal function. The mERG is recorded typically displaying the local 
retinal response of 61 or 103 local regions within the central 45˚ of the posterior pole. The 
responses represent localized cone-driven ERGs obtained in the light adapted state. While 
the waveform morphology of the mERG is similar to the fullfield ERG the electroretinal 
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generator sites of the trough and peak are not equivalent so it is incorrect to use the ‘a-wave’ 
and ‘b-wave’ labels for the mERG. Rather, the major features of the mERG waveform are 
labelled based on polarity and order of appearance, namely, the N1, P1 and N2 components. 
Unlike fullfield flash ERGs which can be seen in response to single flashes, the mERGs are 
highly processed responses obtained to over 16,000 presentations and subject to more 
technical artifacts including eye movement, head tilt, poor refractive capability, and poor 
fixation. There are ISCEV standards for the recording and reporting of mERG (Hood et al. 
2008) that also deal with the identification of artifacts and their solution. 
The ISCEV Standards Committee are also reviewing and examining other ERG techniques, 
parameters and waveforms such as On-Off response and Photopic Negative Response 
(PhNR) and will be developing guidelines and standards for recording and reporting these 
electroretinal responses. 
The expert consensus panel that authored the 2008 ISCEV standards also recognised that 
older ERG recording equipment may not comply with some of the current stimulus 
parameters, including background illumination level and flash stimulus levels, but they 
expressed their hope that manufacturers would strive to update their protocols and comply 
with the most recent standard. The instrument manufacturers are indeed making 
modifications as they bring out new equipment models. The panel tacitly stated that since 
updating non-compliant equipment takes time, publication of data from laboratories that do 
not fully comply with the current standards is permissible provided they clearly indicate all 
variances from the ISCEV protocol. This poses a challenge for any organisation attempting 
to interpret ERG recordings between centers or over time as recordings techniques and 
standards are continually changing 
Two significant sources of variability are the background luminance and the intensity of the 
stimulus flash. The most recent ISCEV standards chose to define the stimulus intensity and 
background luminance as single values rather than acceptable ranges (Marmor et al. 2009, 
118:69-77). They also recognize that differences between equipment and calibration 
fluctuations would cause minor variability in the strength of the stimulus and thus provide 
for a tolerance of ± 10% as an acceptable amount of fluctuation in the standard.  
The ISCEV standards provide a good framework for the establishment of an ERG recording 
system but they are by no means all encompassing. Compliance with ISCEV standards at 
two different sites does not mean recordings of the same patient at two different time points 
are directly comparable. This difficulty in obtaining reproducible ERG tests at different 
centers has hindered the utility of ERG testing in drug development and clinical 
trials.(Chambers 2011)  
There are several challenges encountered in comparing and compiling data between 
different test sites that are important considerations and affect the clinical utility of ERG 
both for individual patients and in clinical trials. The following sections highlight some of 
these challenges and offer suggestions to overcome or decrease   inter-site and inter-test 
variability in ERG recordings. 
2. Equipment issues 
It is the responsibility of the clinical electrophysiologist to ensure that their laboratory 
complies with the published ISCEV standards. The standard states “it is necessary that all 
electrophysiologists master the technical requirements of their chosen electrode, to ensure 
www.intechopen.com
 
Electroretinograms and Normative Data 
 
21 
proper impedance, to ensure that waveforms are comparable to standard ERGs, and to 
define both normal values and variability for their own laboratory.” Essential to the 
adherence to the ISCEV standards is a thorough understanding of the implications of 
variability at all points in the stimulus – recording loop along with implications of 
fluctuations in the environment. In this section we review some of the challenges faced in 
recording ERGs and minimizing inter-site and inter-test variability. 
2.1 The light source problem 
Differences in standardized luminance pose a major challenge to comparing ERGs between 
clinical testing centers. The main problem is an inherent property of the most common light 
source, the xenon flash tube. In xenon flash tubes there is instability produced by arc-
wander which can give rise to random fluctuations of a few percent in light output (Robson 
1998). All Xenon tubes produce  less light as they age necessitating frequent radiometric 
calibration. Unfortunately, due to manufacturing tolerances the working standard of 
radiometry equipment provides an overall uncertainty of about 10% (Ryer 1997). This 
measurement error would be multiplied between sites potentially providing a significantly 
greater amount of inter-site variability. One possible solution to this issue is the recent 
change to light emitting diodes (LEDs) for the ERG stimulus source. 
While LEDs do not have the luminous efficacy of xenon flash tubes they are still a promising 
light source for electroretinography since they can be precisely controlled with regards to 
intensity and flash duration. LEDs show remarkable flash-to-flash stability with less than 
1% variation in light intensity(Robson 2005). In addition, long term output change is around 
1% after 2000 hours of continuous output at an ambient operating temperature of 
+55ºC(Coupland 2004a). In the late 1990’s several investigators began using LED stimulator 
systems for clinical electroretinography in the laboratory and for intra-operative monitoring. 
In 2000, a light-emitting diode flash stimulator became commercially available, the Espion 
ColorBurst™ and Espion ColorDome™ (Diagnosys LLC, Littleton, MA). These systems have 
now been employed as the stimulus for ERG recording systems and have significantly 
reduced inter-test and inter-site variability. 
2.2 Electrode issues 
There are many designs of ERG recording electrodes available, including contact lens, 
gold foil, gold wire, corneal wick, wire loops, microfibers, as well as skin electrodes. The 
clinical ERG is obtained with an electrode placed at some distance from the neural 
elements producing the signals of interest. The electrical current originates in the retinal 
circuitry around the eyeball and orbit, with both spatial and temporal variations. The ERG 
signals are conducted from their retinal generator sites through various tissues to the 
surface electrode. Each electrode type has its own characteristic impedance, recording 
characteristics, and inherent artefacts(Coupland 2004a). 
In 2006 an international survey of ERG electrode use amongst ISCEV members was 
conducted via email(Coupland 2006a). Members were asked which electrode system they 
used most often and their second choice of electrode system. Over 80% of respondents used 
two or more different ERG electrodes in their clinical practice. The majority of respondents 
(52%) use the contact lens electrode as their first choice for clinical electroretinography. The 
second and third most popular choices were the DTL fibre electrode (36%) and the lid hook 
electrode (12%) respectively. There were no respondents who use skin electrodes as their 
electrode of first choice in all their patients.  
www.intechopen.com
 
Electroretinograms 
 
22
Of the 80% of respondents who used a second ERG electrode, lid hook electrodes were 
chosen by 44%; whereas, 21% of these respondents used DTL fibers or contact lens 
electrodes as their second choice. A small number of respondents (12%) indicated they used 
a skin electrode as their second choice; all of these respondents were involved in testing 
paediatric patients. 
Respondents were also asked why they preferred the ERG electrode they were using. Those 
using contact electrodes preferred better signal-to-noise, quality and consistency of recorded 
ERGs, the durability and convenience of the lid speculum were also considered important. 
Those respondents choosing the lid hook electrode preferred better patient acceptance, good 
ERG recording results, the unaltered optical quality provided by lid hook electrodes and 
their ease of use. Those respondents expressing preference for DTL–fiber electrodes were 
impressed with patient acceptance, the electrode’s ease of use, the unaltered optical quality 
provided, the fact that it cannot be blinked out, the electrode is disposable, and that no 
sterilization is needed. Skin electrodes were preferred because of ease of use, patient 
comfort, and the fact that no sterilization was needed. 
As illustrated by this study the choice of recording electrode is varied amongst the members 
of ISCEV. Furthermore, when asked whether clinicians were using the best ERG electrode 
recording system, 72% of respondents expressed agreement; whereas, 20% of respondents 
weren’t sure and 8% of respondents felt they were not using the best electrode available. 
The chief impediments to changing to a better ERG electrode recording system were listed 
as the cost and time needed to collect new normative data, the time for training staff to use 
the new electrode effectively, and the inability to find consistent supplies of disposable 
microfiber electrodes. 
The signal to noise ratio, impedence and sensitivities for each of these electrode systems 
differ considerably (Coupland 2006a). As highlighted by this study it was felt that changing 
the electrode significantly changed the recordings, to the point where the clinical 
electrophyisologist felt it was necessary to recreate the normal database. If comparisons are 
made between recordings from different sites or at different times it is important that same 
electrode system is used to allow these comparisons to be valid. This difference is amplified 
between sites where not only the electrodes are different but the entire recording systems 
are different. 
2.3 Calibration issues 
The Calibration Standard Committee of the ISCEV has provided guidelines for the 
calibration of stimulus and recording parameters used in clinical electrophysiology of vision 
(Brigell et al. 2003, 107:185-193). The document is concerned with both the calibration of the 
visual stimulus including protocols for the measurement of luminous flash intensity, mean 
luminance, contrast and visual angle of pattern stimuli. The photometric measurement of 
luminance levels used for stimulation of the rods is most accurately specified in scotopic 
units. Unfortunately, few photometers have scotopic correction filters available and the 
suggested ISCEV standard is a photopic photometric calibration of the stimulus. This allows 
only an approximation of the rod flash luminance. In our clinical experience many clinical 
laboratories do not have appropriate technology or familiarity with both photopic and 
scotopic photometric calibration. The use of automated calibration routines can be usefully 
applied to optoelectronic (i.e. light emitting diode) stimulators and at least one 
manufacturer has incorporated internal calibration of their LED stimulator. While the ISCEV 
standard requires the calibration of Ganzfeld strobe flash and background luminance is 
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performed at least every 6 months, in reality the frequency of calibration varies widely 
across different laboratories. Some equipment manufacturers have provided internal 
reminders to prompt users to perform calibration, this is particularly useful if internal 
automated calibration systems are provided. 
The ISCEV standards also provide guidelines for the calibration of electrophysiological 
recording systems and include protocols for the measurement of electrode impedance and 
amplifier calibration(Brigell, Bach, Barber, Moskowitz, and Robson 2003, 107:185-193). The 
calibration of amplifiers is particularly challenging since most manufacturers do not provide 
a standard calibrator to pass a known signal through the system to measure the system 
output. Suitable signal generators must be capable of producing low amplitude output 
using both sine wave and square wave pulses. The use of both sine wave and square wave 
calibration signals allows detection of unwanted harmonic distortion and assesses the 
filtering characteristics of the amplifiers themselves(Brigell, Bach, Barber, Moskowitz, and 
Robson 2003, 107:185-193). The ISCEV standards committee is presently communicating 
with equipment manufacturers to develop appropriate standardized calibrators.  
With increasing use and popularity of optoelectronic stimulation, internal calibration is 
essential because the luminous intensity of an LED is temperature dependent.  This means 
that as temperature linearly increases or decreases, the light intensity of an LED 
exponentially decreases or increases respectively. Red and amber LEDs are more sensitive to 
temperature effects than blue and green LEDs. Some ERG systems (e.g. Diagnosys LLC, 
Lowell, MA) utilizing an LED stimulator provide the user with the ability to perform 
internal calibration of the LED system once the system is turned on or it can be evoked 
every time a new test is selected. Presently, the ISCEV standards do not address calibration 
of LED systems, but this should be rectified in the next revision of the standards.  
2.4 Conclusions 
The ISCEV standards provide a good basis for creation of an ERG recording system. 
However it is incumbent on the electrophyisologist managing the recording laboratory to 
ensure that the equipment is properly and regularly calibrated and that the recording 
technique is standardised and conforms to ISCEV standards. 
3. Normative data 
Dorland’s Medical Dictionary defines Normal as “agreeing with the regular and established 
type.”(Dorland 2003) Typically in medicine this is taken as the mean ± 95% confidence 
intervals for a given population. Thus an ERG response for a given type of stimulation 
would be normal if it fell with-in the 95 % confidence intervals for that type of recording. 
The challenge however is defining the 95% confidence intervals for ERG. 
The need to establish a new normative database as indicated in Coupland’s 2006 survey of 
ISCEV members is a major hindrance to changing or updating any electrophysiological 
system(Coupland 2006a).  To date few companies supply a normative database which can 
negate the need to carry out on site testing to establish site specific guides for normative 
values.  This is contrary to most diagnostic equipment utilized in ophthalmology and is in 
part due to the inherent variability in recording systems identified above. Population 
specific factors such as age, race, pupil size, axial length, and diurnal variation, impact the 
ability to establish a normative database; these issues are addressed in this section. 
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3.1 Age factors 
The effect of age on ERG parameters has been well demonstrated(Birch and Anderson 1992, 
110:1571-1576;Peterson 1968:Suppl-77;Weleber 1981, 20:392-399). Birch and Anderson(Birch 
and Anderson 1992, 110:1571-1576) for instance described ERGs in 270 normal subjects 
recorded under the ISCEV standard and ranging in age from newborn to 79 years. The mean 
log amplitude of both rod and cone responses increased from birth reaching its maximum at 
around 25 years and then showed a progressive decline with age. While the exact factors 
causing the decrease in ERG amplitude in the elderly are not well understood, it is likely 
that preretinal media changes, reduction in photopigment optical density with age, or 
bipolar and/or Müller cell degeneration with aging could account for such age-related 
amplitude reduction (1992). 
Similar changes are observed at the other end of the age spectrum. Both scotopic and 
photopic ERGs are recordable at birth. There is a rapid increase in b-wave amplitude during 
the first 4 months in the neonatal period. By 6 months of age, b-wave scotopic sensitivity has 
become equivalent to that of adults(Fulton 1988, 69:101-109). Development of normal, rod-
mediated vision in human infants is primarily based on studies of electroretinal function, 
and psychophysical adaptation to bleaching lights as well as adaptation to steady 
background lights. Presently, it is thought that early postnatal development of human 
scotopic function reflects the reorganization of the inner retinal circuitry(Fulton 1988, 69:101-
109). 
As with most diagnostic tests in medicine, it is important to compare any ERG recording 
with age matched normal subjects – but this significantly increases the number of ERG 
recordings required to establish a normative database. This task becomes even more 
monumental when one takes into consideration ethnic diversity. 
3.2 Ethnic diversity 
Coupland et al., (2006b) described an international study of the ERG in normals using the 
same ERG equipment and protocol at two centers in the Peoples Republic of China and in 
Canada. It is assumed that any observed differences in ERG parameters would likely reflect 
true population differences rather than variations resulting from instrumentation or 
methodology. Two similar aged populations were recruited and identical recording 
methodology was employed. Interestingly, there were no significant differences observed in 
a- and b-wave peak latency (i.e. implicit time) between the two groups; however, there were 
statistically significant differences in b-wave amplitude observed for the scotopic rod, 
scotopic mixed rod-cone, photopic cone and 30 Hz flicker ERGs, with amplitudes being 
significantly larger in the Canadian subjects. They proposed that the observed b-wave 
amplitude differences observed were due to increased axial length in Chinese eyes as 
evidenced by increased mean (myopic) refractive error. This study demonstrated a 
correlation between axial length and b-wave amplitudes and implicit times suggesting 
individuals with pathological myopia may result in falsely abnormal values if these factors 
are not reflected in the normative database.  
3.3 Gender 
Gender differences in ERG b-wave amplitude have been noted by several investigators 
(Birch and Anderson 1992, 110:1571-1576;Peterson 1968:Suppl-77). Peterson (Peterson 
1968:Suppl-77) first noted that females had statistically significant larger b-wave amplitude 
in all ages from 10 to 50 years. A similar small but statistically significant affect of gender 
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was also demonstrated by Birch and Anderson(Birch and Anderson 1992, 110:1571-1576) 
showing slightly smaller amplitude which they and others thought likely due to greater 
axial length in males. Thus comparing a female subject to a normative database of males 
would not be valid.  
3.4 Pupil size 
Retinal illumination is proportional to pupil area. Coupland (2004) reported dilated pupil 
size in 400 consecutive patients between ages 10 and 90 years and found the dilated pupil 
size varied from 4 to 9.5 mm and was significantly correlated with age (p<0.001) (Figure 1). 
Since there was significant variation in dilated pupil size with age in the clinical population, 
the affect of this was studied in a small group of patients in which dilated pupil size could 
be strictly controlled through a set of custom made soft contact lenses with artificial pupil 
sizes of 4 and 6 mm (Figure 2). ERGs obtained to a photopic ISCEV standard flash were 
measured in subjects against their normal fully dilated pupil and then through a 4 mm and 
6 mm artificial pupil. Variability of dilated pupil size can significantly affect amplitude and 
implicit time obtained using standard flash ERG. 
 
 
Fig. 1. Dilated Pupil size decreases with increasing age (Line of best fit = 8.487-0.24 x Age; 
R2=0.228). Adapted from Coupland (2004). 
3.5 Diurnal variation in ERG 
Birch et al.(Birch, Berson, and Sandberg 1984, 25:236-238) described the range of diurnal 
variation for the rod b-wave amplitude to beapproximately a 13% reduction occurring 1.5 
hours after the onset of daylight. Interestingly, this time period corresponds to the point of 
maximum rod outer segment disc shedding. ERG b-waves become largest by midday. In a 
larger study of circadian rhythm on the dark-adapted ERG, Nozaki et al.,(Nozaki, 
Wakakura, and Ishikawa 1983, 27:346-352) reported that a-wave amplitude showed no 
circadian rhythm. B-wave amplitudes were also noted to be lowest around 6 a.m. and 
highest at midday. B-wave amplitude showed no direct correlation with corticosteroid 
levels but did show correlation with dopamine β-hydroxylase. Melatonin level has also been 
found to affect the ERG (Fufiange et al. 2002). Significant inverse correlation was found 
between salivary melatonin level and ERG b-wave amplitude; when melatonin levels were 
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highest, the ERG b-wave amplitude was lowest(Rufiange, Dumont, and Lachapelle 2002, 
43:2491-2499). These findings suggest that the ERG recordings in patients during clinical 
trials, to monitor patient improvement or progression, are best performed at approximately 
the same time of day. 
 
 
 
 
 
 
Fig. 2. B-wave amplitude decreases with decreasing pupil size. A: Contact lens with 
standardized apertures were used to simulate a fixed sized pupil in dilated normal 
individuals. B: the ERG responses to a standard flash (3 cd·s/m2) in these experiments show 
a decrease in the b-wave amplitude of >40% in these normal individuals with decreasing 
pupil size. Adapted from Coupland (2004). 
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3.6 Recording conditions 
The effects of environmental conditions on the recording equipment have been outlined 
above. These conditions also affect the subject and can adversely impact the quality of the 
recordings obtained. In a study looking at optimization of visual evoked potentials (VEP), 
Karanjia et al.,(Karanjia, Brunet, and ten Hove 2009, 36:89-92) were able to demonstrate that 
use of a recumbent position improved the signal to noise ratio for the recordings. Failure to 
attend to patient positioning can artificially alter the quality and amplitude of all types of 
electrophysiological recordings and thus must be consistently addressed during the 
recording of ERGs. 
3.7 Conclusions 
This information demonstrates the need for appropriately selecting subjects for a normative 
database. Databases which are homogenous for one ethnic group, of a single age group or 
refractive state may not accurately reflect the normative data range for individual subjects 
who do not match those demographics. Furthermore, consistency in recording time and 
technique is essential as variation in pupil size from inadequate dilatation may artificially 
alter the amplitude of the recording. Thus, it is important that the subject be comfortable 
and tested under consistent conditions including the time of day. 
As illustrated in Coupland’s survey (2006a) the need for site specific normative databases is 
a serious impediments to the individual laboratory adapting new recording equipment or 
techniques. Establishing a new normative database is labour intensive, time-consuming and 
expensive. The solution, it might seem, would be a cooperative multicenter collaboration for 
normative ERG data collection. The advantages would include a reduction in cost, resources 
and testing time to those participant sites. The challenges posed by recording at different 
sites is addressed in the following section. 
4. Multicenter recordings 
Conflicting findings between testing sites have been published since the early days of ERG. 
For example Sabates et al.,(Sabates, Hirose, and McMeel 1983, 101:232-235) looked at the b/a 
wave ratio as a surrogate of inner retinal function in patients with central retinal vein 
occlusion (CRVO). This study was based on the understanding that the a-wave represents 
outer retinal function and thus the neurons responsible for this component of the ERG 
would be supported by choroidal circulation, whereas the b-wave is representative of the 
neuronal activity of the inner retina, supplied by the central retinal artery and thus more 
likely to be damaged in a CRVO. Sabates found that a b/a ratio of less than one was 
correlated with a higher likely hood of a patient having neovascularisation of the iris (NVI) 
as a result of the CRVO.  
Sabates’s finding was refuted by Johnson et al.,(Johnson et al. 1988, 106:348-352) found that 
b/a ratios were greater than unity in 8 out of 9 patients who subsequently developed NVI 
when a maximal stimulus amplitude luminance was utilized. While Johnson and Sabates 
results appear to be at odds with each other it is important to note that several key 
difference existed between Sabates and Johnsons recording systems.  
Differences in the luminance for both sets of experiments coupled with differences in the 
type of recording electrode, Ganzfeld stimulator, and recording equipment only 
compounded any difference in the signals recorded at the two sites. These issues make it 
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virtually impossible to directly compare data collected in the two studies and similar 
limitations still exist today when trying to compare or compile data from multiple sites.  
Over two decades has passed since Sabates’s and Johnson’s studies and a basic ERG 
protocol has been standardized for certain responses since 1989(Marmor 1989, 73:299-302). 
This ERG standard has since been updated three times, most recently in 2008(Marmor et al. 
2009, 118:69-77) and in theory would allow for comparison of recordings throughout the 
world. The guidelines include recommendations for commercial recording instrumentation 
to allow for the recording of the standard five ERG responses and in conjunction with 
numerous commercially available electro-diagnostic systems. Given the number of 
manufactures of stimulus and recording equipment and number of permissible recording 
techniques, the number of possible combinations and subsequent variability, remains very 
large. 
 
A: 
 
 
B: 
 
Fig. 3. Fifteen serial ERG recordings from 15 Espion e2 (Diagnosys LLC, Lowell, MA) 
electrodiagnostic instruments. ERGs were recorded to 3 cd·s/m2 flash through undilated 
pupils in a single subject, ND using DTL-Plus Diagnosys LLC, Lowell, MA) 
microconductive fiber electrode. A: ERGs were repeated at each site to demonstrate 
replicability. B: Overlay of all recordings demonstrates consistent A and B wave response 
amplitudes and latencies across all recordings. (The authors would like to thank Natalie Doran 
and Diagnosys LLC for providing the ERGs used in this illustration.) 
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The greatest impediment to collaborative multicenter data collection is this inter-site 
variability in ERG recording parameters. In order to utilize multi-site data collection the two 
main sources of inter-site variance; differences in recording methodology and differences in 
standardized stimulus luminance; would need to be addressed. Inter-site variability 
resulting from differences in recording methods (e.g. different recording electrodes, filter 
settings, adaptation time, inter-flash intervals etc.) can be largely controlled through 
standardization. When a single recording system and protocol is used a consistent ERG 
recording can be obtained at different test centres (Figure 3). All fifteen sets of recordings 
were done on a single subject and show consistent a- and b-wave amplitude and latency. In 
order for ERGs to have a use in clinical trials recordings between test centres need to be 
consistent. Figure 3 clearly illustrates that this is possible provided the appropriate care and 
protocols, as discussed below, are in place.  
4.1 ERG and clinical trials 
The strength of ERG recordings as a primary or secondary endpoint lies in the quantitative 
objective nature of the recordings. Yet the clinical significance of decreased ERG amplitudes 
or delay is not always clear in clinical trials setting. 
The US FDA Center for Drug Evaluation and Research is responsible for monitoring the drug 
development process as well as approving new drug products and monitoring adverse events 
after approval has been granted. ERG is first used in preclinical studies on drugs that are 
intended to affect electrophysiology, bind with melanin, or cause retinal lesions (Chambers 
2011). In clinical studies ERGs are used as outcome measures to assess therapeutic efficacy as 
well as monitor potential retinal toxicity when demonstrated ERG abnormalities have been 
shown in animal studies. In human clinical trials ERG is often used as a secondary endpoint 
although it has been used as a primary endpoint in a recent safety study(Cordell et al. 2009, 
127:367-373). FDA does not usually set ERG testing standards and generally accepts the ISCEV 
standards(Chambers 2011). To date changes greater than 40% in b-wave amplitude from 
baseline have been accepted as clinically significant(Cordell, Maturi, Costigan, Marmor, 
Weleber, Coupland, Danis, McGettigan, Antoszyk, Klise, and Sides 2009, 127:367-373). 
4.2 ERG and multicenter clinical trials 
ERG has the potential to provide objective information on retinal function and thus is highly 
desirable in clinical trials. The difference in recording technique and equipment, however, 
make interpretation between centers a major challenge to the clinical utility of ERG.  
New clinical trials may soon be obligated by the FDA to include ERG as one of the outcome 
measures if a medication is intended to directly affect the electrophysiology of cells or if 
there has been demonstrated ERG abnormality in animal studies(Chambers 2011). Given 
this FDA mandate for ERG testing as part of new drug development the ability to record 
from subjects at different centers during a multicenter clinical trial is becoming a necessity. 
To date there is one multicenter clinical trial which utilized ERG as a primary endpoint and 
it provides an excellent case study on how to address the challenges of multicenter ERG 
recordings(Cordell, Maturi, Costigan, Marmor, Weleber, Coupland, Danis, McGettigan, 
Antoszyk, Klise, and Sides 2009, 127:367-373). 
4.3 Standardized multicenter clinical trial 
Cordell et al.,(Cordell, Maturi, Costigan, Marmor, Weleber, Coupland, Danis, McGettigan, 
Antoszyk, Klise, and Sides 2009, 127:367-373) were mandated to look at potential for retinal 
toxicity for tadalafil or sildenafil by the FDA, in a post market Phase IV clinical trial 
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conducted at 15 US clinics using standardized ERG equipment and protocols. ERG was 
selected as the primary measure of retinal toxicity in this clinical trial as it provided 
objective quantities measure of retinal function. Subjects were recruited at 15 centers within 
the United States mandating that ERG testing be conducted at all 15 centers. In order to 
overcome the technical limitations to multicenter recordings all centers used the same 
standardized equipment, the same ERG protocol, and a single normative data set with a 
single website based ERG reading center. In the process they have established guidelines 
which address the challenges of multicenter ERG recordings with a variety of technical and 
logistical solutions for the use of ERG in future clinical trials. 
4.3.1 Personnel and training 
Consistency of outcome across multiple testing sites can only be ensured through 
appropriate training and consistent monitoring of ERG outcomes to maintain quality 
assurance standards and this is one of the roles of the ERG reader. It is critical that all sites 
submit standardized ERG tests on normal subjects and empirically demonstrate consistency 
before receiving certification for multicenter trials.  
Appropriately trained technologists are critical for multicenter ERG clinical trials. 
Preferably, all centers should be trained by the same trainer to ensure consistency of 
technique. On-site visit during patient testing confirms performance consistency at the 
individual site. In the Cordell et al., (2009) study, all 15 sites received centralized training on 
the east and west coasts (Washington DC and Scottsdale Arizona). In addition, all 15 sites 
received individualized on-site refresher training all within a 4-week period following 
centralized training. Reproducibility and consistency of ERGs obtained on individual non-
clinical trial patients at multiple sites were assessed through a centralized web-based ERG 
reading center. Through the use of standardised training and protocols this study was able 
to demonstrate that ERG is a viable method of compiling objective multicenter data with 
low levels of inter-site variability.  
4.3.2 Role of ERG reader 
The ERG reviewer or ERG reader performs two vital roles in clinical trials using ERGs as 
clinical endpoints. The primary role is to monitor quality and consistency in reproducibility 
of ERGs submitted from clinical sites. It is essential that ERGs have quality assurance review 
in order that they are interpreted correctly. Technical artefact such as power mains 
interference, eye blink and eye movement, high frequency noise, electrical spiking, and 
other myogenic interference can produce spurious changes in waveform morphology which 
could be incorrectly interpreted. The secondary role of the ERG reader is to determine if 
there have been objective quantitative or subjective qualitative changes in ERG findings 
over time. It is critical that the ERG reader be blind to both patient identification and 
experimental clinical trial condition. This reduces the degree of bias as does the reliance on 
statistical criteria for determining ERG change.  
When multiple ERG readers are used in large clinical trials a process for conflict resolution 
is necessary. In order to maintain consistency of quality of ERG interpretation it is essential 
that all readers review all waveforms or all those waveforms that are deemed to fall outside 
of normal limits and agree that significant changes in ERG amplitude and timing have 
occurred. It is essential that criteria for determining ERG change be determined before the 
clinical trial begins. 
www.intechopen.com
 
Electroretinograms and Normative Data 
 
31 
Multicenter recording protocols such as the one employed in Cordell et al., (2009) benefited 
from having a centralised electronic database of all the recordings. This allowed multiple 
readers to assess the complete set of data and make independent evaluations of the ERGs. 
Conflicting interpretations were then reassessed as a group using the predetermined criteria 
established prior to the commencement of recruitment. The acceptance of this clinical trial 
by the FDA provides tacit approval of the methodology employed in Cordell et al., (2009).  
4.4 Conclusions 
As an objective measure of retinal function ERG is poised to play a major role in clinical 
trails. Cordell et al., (2009) provides a framework by which one can run a successful 
multicenter clinical trial that utilizes ERG as a primary endpoint. Their success was 
dependent on standardization of not just the recording equipment but the training and 
personnel, both technicians and ERG readers, involved in the trial. 
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